JPH0319388Y2 - - Google Patents
Info
- Publication number
- JPH0319388Y2 JPH0319388Y2 JP16338685U JP16338685U JPH0319388Y2 JP H0319388 Y2 JPH0319388 Y2 JP H0319388Y2 JP 16338685 U JP16338685 U JP 16338685U JP 16338685 U JP16338685 U JP 16338685U JP H0319388 Y2 JPH0319388 Y2 JP H0319388Y2
- Authority
- JP
- Japan
- Prior art keywords
- cervix
- laminaria
- drug administration
- tube
- rod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000003679 cervix uteri Anatomy 0.000 claims description 25
- 238000001647 drug administration Methods 0.000 claims description 18
- 210000004291 uterus Anatomy 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 8
- 230000035935 pregnancy Effects 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 2
- 230000000916 dilatatory effect Effects 0.000 claims 1
- 241001466453 Laminaria Species 0.000 description 20
- 238000010586 diagram Methods 0.000 description 7
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 4
- 206010000210 abortion Diseases 0.000 description 3
- 231100000176 abortion Toxicity 0.000 description 3
- 230000008602 contraction Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16338685U JPH0319388Y2 (enExample) | 1985-10-24 | 1985-10-24 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16338685U JPH0319388Y2 (enExample) | 1985-10-24 | 1985-10-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6272652U JPS6272652U (enExample) | 1987-05-09 |
| JPH0319388Y2 true JPH0319388Y2 (enExample) | 1991-04-24 |
Family
ID=31091534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16338685U Expired JPH0319388Y2 (enExample) | 1985-10-24 | 1985-10-24 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0319388Y2 (enExample) |
-
1985
- 1985-10-24 JP JP16338685U patent/JPH0319388Y2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6272652U (enExample) | 1987-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250017763A1 (en) | Intra uterine device | |
| Jones Jr et al. | On the transfer of conceptuses from oocytes fertilized in vitro | |
| US3911911A (en) | Anti-fertility device | |
| EP0330786B1 (en) | Topical drug delivery systems containing danazol | |
| US3374788A (en) | Contraceptive devices and methods | |
| US4416660A (en) | Method of transvaginal sterilization | |
| WO1994024944A1 (en) | Method, device and apparatus for reversible contraceptive sterilization | |
| JPH0319388Y2 (enExample) | ||
| Mikhail et al. | Oestriol metabolism in the human foeto-placental unit | |
| US5095010A (en) | Antigestagens, glucocorticoids and prostaglandins for induction of labor or for termination of pregnancy | |
| Tang et al. | Medical abortion in the second trimester | |
| EP0501056A1 (en) | Danazol containing compositions for the treatment of endometriosis | |
| CN115243649B (zh) | 一种带有锁定部分的子宫内系统 | |
| Craft et al. | Intra-amniotic prostaglandin F2α and urea for abortion | |
| Cheng et al. | Preoperative cervical dilatation with 15 (S) 15 methyl prosta-glandin E2 methyl ester in first trimester nulliparae—a double blind study | |
| Fylling et al. | Rivanol-induced mid-trimester abortion: Report on 200 cases | |
| JPH0527421B2 (enExample) | ||
| CN219814469U (zh) | 一种立体型宫内节育器 | |
| Leader et al. | Vaginally administered 16, 16-dimethyl-prostaglandin E2 as an agent for pre-operative cervical dilatation | |
| CN110393604A (zh) | 用于动物的口服固体制剂给药装置 | |
| WO2019211832A1 (en) | Localized delivery of an active agent | |
| Karim | The induction of abortion with prostaglandins | |
| Filshie | Medical and surgical methods of early termination of pregnancy | |
| Overmyer | RU-486: preparing for the abortion drug | |
| JPH0119967Y2 (enExample) |